New test for diagnosing amoxicillin allergy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to validate a novel T-cell activation test for diagnosing amoxicillin allergy. Participants will undergo blood collection and, when applicable, allergy skin testing during multiple hospital visits. The study focuses on improving the reliability and applicability of allergy diagnostics, addressing the challenges of current testing methods. By utilizing flow-based intracellular trapping and staining techniques, the researchers hope to create a safe and effective diagnostic tool that could streamline the identification of drug allergies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Participants are eligible if they:

* Are ≥ 6 years
* Are capable of informed consent, or if appropriate, participants have an acceptable individual capable of giving consent on the participant's behalf (e.g. parent or guardian of a child under 18 years of age)
* Have a suspected history of amoxicillin allergy

Exclusion Criteria:

* Patients who are lacking capacity or do not have an acceptable individual capable to provide informed consent
* Pregnant women
* Breastfeeding women

Where it's running

• Antwerp University Hospital
  Edegem, Antwerp, Belgium Recruiting

Study contacts

• Principal investigator: Didier Ebo, PhD — University Hospital, Antwerp
• Study coordinator: Didier Ebo, PhD
• Email: Didier.Ebo@uza.be
• Phone: +3238215027

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Anatomy-based fitting for single-sided deaf CI users

  This study tests whether anatomy-based fitting changes how well adults with single-sided deafness use a cochlear implant to understand speech in noise and to enjoy music.

  Recruiting University Hospital, Antwerp · Antwerp · NCT07703800

• Eccentric Muscle Training in Cardiac Rehab for Heart Failure with Reduced Ejection Fraction

  This study tests eccentric overload and eccentric cycling as part of a cardiac rehabilitation program for people with HFrEF to see if they build more muscle strength and mass than traditional training.

  Recruiting University Hospital, Antwerp · Edegem · NCT07636343

• Methylation markers from saliva to guide lung cancer screening

  This study tests whether DNA methylation patterns in saliva can more accurately identify people who should get a low-dose CT scan for lung cancer screening.

  Recruiting University Hospital, Antwerp · Antwerp, Antwerpen · NCT07631624

• Following therapy response with a blood test (liquid biopsy) in metastatic colorectal cancer

  This trial tests whether using a blood test that measures NPY-methylation ctDNA to guide treatment decisions helps people with unresectable metastatic colorectal cancer who are starting first-line therapy.

  Recruiting at 9 sites Phase 3 University Hospital, Antwerp · Mechelen, Antwerpen and 8 other locations · NCT07558083

• New ways to measure heart changes in sleep apnea

  This study tests whether beyond-the-ordinary sleep apnea metrics can reveal cardiovascular changes and compares CPAP, MADs, and hypoglossal nerve stimulation in adults with OSA.

  Recruiting University Hospital, Antwerp · Antwerp · NCT07427589

• Endotracheal tube leak patterns to predict post-extubation stridor in children

  This project will test whether detailed leak measurements from a child's breathing tube can help predict who will develop noisy breathing (post-extubation stridor) after the tube is removed.

  Recruiting University Hospital, Antwerp · Antwerp, Antwerp · NCT07414472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.